Ro, a US-based telehealth diagnostics company, has announced an integration with NovoCare Pharmacy with the intention of providing seamless access to all doses of Wegovy at the best available cash price of USD499 per month.

By working directly with Denmark-based Novo Nordisk's direct-to-patient option NovoCare Pharmacy, Ro aims to ensure that patients have a reliable supply of FDA-approved GLP-1 medication directly from the manufacturer. Patients can consult with a provider and get access to effective GLP-1 medication at the lowest cash price, without leaving the Ro app.

Ro vertically integrates telehealth, lab and pharmacy services in one platform. With the Body Membership, patients have access to obesity care including access to a licensed physician, 24/7 messaging, 1-1 coaching, educational content, weight tracking and dose logging, labs, side-effect monitoring and monthly check-ins to handle everything from dose titration to counselling.

The company said that with the Ro Insurance Checker, anyone can verify their benefits coverage for free and find the best possible medication choice at the lowest possible price -- whether that's using insurance coverage or paying cash.